UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Phase II Study of Docetaxel, Estramustine, and Low-Dose Hydrocortisone in Men With Hormone-Refractory Prostate Cancer: A Final Report of CALGB 9780

Journal of clinical oncology, 2001-05, Vol.19 (9), p.2509-2516

2001

Volltextzugriff (PDF)

Preoperative chemoradiation coupled with aggressive resection as needed ensures near total control in advanced head and neck cancer

The American journal of surgery, 1997-11, Vol.174 (5), p.518-522

1997

Volltextzugriff (PDF)

Outcomes Among African-American/Non-African-American Patients With Advanced Non-Small-Cell Lung Carcinoma: Report From the Cancer and Leukemia Group B

JNCI : Journal of the National Cancer Institute, 2002-02, Vol.94 (4), p.284-290

2002

Volltextzugriff (PDF)

Neutrophil activation through high-affinity Fcγ receptor using a monomeric antibody with unique properties

Blood, 1991-02, Vol.77 (3), p.607-615

1991

Volltextzugriff (PDF)

Prostate-specific antigen response to withdrawal of megestrol acetate in a patient with hormone-refractory prostate cancer

Mayo Clinic proceedings, 1997-10, Vol.72 (10), p.932-934

1997

Volltextzugriff (PDF)

Paradoxical influence of estrogenic hormones on platelet-endothelial cell interactions

Thrombosis research, 1994-06, Vol.74 (6), p.577-594

1994

Volltextzugriff (PDF)

Oral Metoclopramide With or Without Diphenhydramine: Potential for Prevention of Late Nausea and Vomiting Induced by Cisplatin

JNCI : Journal of the National Cancer Institute, 1988-08, Vol.80 (11), p.864-868

1988

Volltextzugriff (PDF)

Erlotinib as first-line treatment for untreated advance stage NSCLC with good prognosis

Journal of clinical oncology, 2006-06, Vol.24 (18_suppl), p.7178-7178

Akerley, W. L.

2006

Volltextzugriff (PDF)

Contemporary Adjuvant Treatment of Breast Cancer

Surgical oncology clinics of North America, 1995-10, Vol.4 (4), p.685-699

Akerley, Wallace L.

1995

Volltextzugriff (PDF)

Impact of COVID-19 Pandemic on Healthcare Delivery, Behavioral Outcomes, and Financial Stress in 1,253 Individuals with Cancer at Huntsman Cancer Institute (HCI)

Cancer epidemiology, biomarkers & prevention, 2021-04, Vol.30 (4), p.805-805

2021

Volltextzugriff (PDF)

A single-arm phase II trial evaluating docetaxel, vinorelbine, and GM-CSF in stage IV melanoma

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.8546-8546

2011

Volltextzugriff (PDF)

Bevacizumab/erlotinib (BEER) as first-line treatment for untreated, advanced non-squamous non-small cell lung cancer (NSNSCLC)

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.e18008-e18008

2010

Volltextzugriff (PDF)

Final report: Combination of MPC-6827 with temozolomide for the treatment of patients with metastatic melanoma

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.8531-8531

2010

Volltextzugriff (PDF)

Catumaxomab treatment of malignant ascites in patients with chemotherapy-refractory ovarian cancer: A phase II study

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.5048-5048

2011

Volltextzugriff (PDF)

Results from ARQ 197-209: A global randomized placebo-controlled phase II clinical trial of erlotinib plus ARQ 197 versus erlotinib plus placebo in previously treated EGFR inhibitor-naive patients with locally advanced or metastatic non-small cell lung cancer (NSCLC)

Journal of clinical oncology, 2010-06, Vol.28 (18_suppl), p.LBA7502-LBA7502

2010

Volltextzugriff (PDF)

Randomized phase II trial of sorafenib (SO) with temsirolimus (TEM) or tipifarnib (TIPI) in metastatic melanoma: Southwest Oncology Group Trial S0438

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.8502-8502

2010

Volltextzugriff (PDF)

A clinical study investigating MPC-6827 with carboplatin in the treatment of patients with relapsed glioblastoma multiforme

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.2095-2095

2010

Volltextzugriff (PDF)

A randomized phase 2 trial of combretatstatin A4 phosphate (CA4P) in combination with paclitaxel and carboplatin to evaluate safety and efficacy in subjects with advanced imageable malignancies

Journal of clinical oncology, 2007-06, Vol.25 (18_suppl), p.14060-14060

2007

Volltextzugriff (PDF)

Adjuvant treatment of breast cancer

Rhode Island medicine, 1995-09, Vol.78 (9), p.250

Akerley, 3rd, W L

1995

Volltextzugriff (PDF)

Acceptable safety of bevacizumab therapy in patients with brain metastases due to non-small cell lung cancer

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.8043-8043

2008

Volltextzugriff (PDF)

Racial comparison of outcomes of male Department of Veterans Affairs patients with lung and colon cancer

Archives of internal medicine (1960), 1993-07, Vol.153 (14), p.1681

1993

Volltextzugriff (PDF)

SWOG 0019: A phase II study of gemcitabine and irinotecan for patients with untreated extensive stage small cell lung cancer (SCLC)

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.7202-7202

2004

Volltextzugriff (PDF)

SWOG 0019: A phase II study of gemcitabine and irinotecan for patients with untreated extensive stage small cell lung cancer (SCLC)

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.7202-7202

2004

Volltextzugriff (PDF)

Comparison of Metoclopramide and Metoclopramide Plus Dexamethasone for Complete Protection from Cisplatinum-Induced Emesis

Cancer investigation, 1986, Vol.4 (5), p.379-385

1986

Volltextzugriff (PDF)

Phase II study of docetaxel, estramustine, and low-dose hydrocortisone in men with hormone-refractory prostate cancer: a final report of CALGB 9780. Cancer and Leukemia Group B

Journal of clinical oncology, 2001-05, Vol.19 (9), p.2509

2001

Volltextzugriff (PDF)

1 – 25 von 107

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(103)
Mit Volltextzugriff
(75)

Publikationsform

Sprache

Englisch
(107)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

Humans
(52)
Science & Technology
(45)
Life Sciences & Biomedicine
(42)
Oncology
(31)
Female
(27)
Middle Aged
(27)
Male
(26)
Adult
(23)
Aged
(22)
Biological And Medical Sciences
(21)
Medical Sciences
(21)
Chemotherapy
(14)
Combined Modality Therapy
(13)
Lung Neoplasms - Therapy
(12)
Pharmacology. Drug Treatments
(12)
Aged, 80 And Over
(11)
Antineoplastic Agents
(11)
Carcinoma, Non-Small-Cell Lung - Therapy
(11)
Neoplasm Staging
(11)
Carcinoma, Non-Small-Cell Lung - Pathology
(10)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Phase II Study of Docetaxel, Estramustine, and Low-Dose Hydrocortisone in Men With Hormone-Refractory Prostate Cancer: A Final Report of CALGB 9780

Preoperative chemoradiation coupled with aggressive resection as needed ensures near total control in advanced head and neck cancer

Outcomes Among African-American/Non-African-American Patients With Advanced Non-Small-Cell Lung Carcinoma: Report From the Cancer and Leukemia Group B

Neutrophil activation through high-affinity Fcγ receptor using a monomeric antibody with unique properties

Prostate-specific antigen response to withdrawal of megestrol acetate in a patient with hormone-refractory prostate cancer

Paradoxical influence of estrogenic hormones on platelet-endothelial cell interactions

Oral Metoclopramide With or Without Diphenhydramine: Potential for Prevention of Late Nausea and Vomiting Induced by Cisplatin

Erlotinib as first-line treatment for untreated advance stage NSCLC with good prognosis

Contemporary Adjuvant Treatment of Breast Cancer

Impact of COVID-19 Pandemic on Healthcare Delivery, Behavioral Outcomes, and Financial Stress in 1,253 Individuals with Cancer at Huntsman Cancer Institute (HCI)

A single-arm phase II trial evaluating docetaxel, vinorelbine, and GM-CSF in stage IV melanoma

Bevacizumab/erlotinib (BEER) as first-line treatment for untreated, advanced non-squamous non-small cell lung cancer (NSNSCLC)

Final report: Combination of MPC-6827 with temozolomide for the treatment of patients with metastatic melanoma

Catumaxomab treatment of malignant ascites in patients with chemotherapy-refractory ovarian cancer: A phase II study

Results from ARQ 197-209: A global randomized placebo-controlled phase II clinical trial of erlotinib plus ARQ 197 versus erlotinib plus placebo in previously treated EGFR inhibitor-naive patients with locally advanced or metastatic non-small cell lung cancer (NSCLC)

Randomized phase II trial of sorafenib (SO) with temsirolimus (TEM) or tipifarnib (TIPI) in metastatic melanoma: Southwest Oncology Group Trial S0438

A clinical study investigating MPC-6827 with carboplatin in the treatment of patients with relapsed glioblastoma multiforme

A randomized phase 2 trial of combretatstatin A4 phosphate (CA4P) in combination with paclitaxel and carboplatin to evaluate safety and efficacy in subjects with advanced imageable malignancies

Adjuvant treatment of breast cancer

Acceptable safety of bevacizumab therapy in patients with brain metastases due to non-small cell lung cancer

Racial comparison of outcomes of male Department of Veterans Affairs patients with lung and colon cancer

SWOG 0019: A phase II study of gemcitabine and irinotecan for patients with untreated extensive stage small cell lung cancer (SCLC)

SWOG 0019: A phase II study of gemcitabine and irinotecan for patients with untreated extensive stage small cell lung cancer (SCLC)

Comparison of Metoclopramide and Metoclopramide Plus Dexamethasone for Complete Protection from Cisplatinum-Induced Emesis

Phase II study of docetaxel, estramustine, and low-dose hydrocortisone in men with hormone-refractory prostate cancer: a final report of CALGB 9780. Cancer and Leukemia Group B

Suchergebnisse filtern